BMEA - CIK 0001840439
The table below shows Biomea Fusion, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$70.37M | -$119.89M | -$96.59M | -$62.42M | -$35.44M | -$4.46M |
| Capital expenditure | - | $362.00K | $3.37M | $1.03M | $3.17M | $51.00K |
| Investing cash flow | - | -$362.00K | -$2.22M | $27.34M | -$33.35M | -$51.00K |
| Dividends paid | - | - | - | - | - |
Biomea Fusion, Inc. reported operating cash flow of -$70.37M for fiscal year 2025. That is up 41.3% from -$119.89M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from -$1.28M (FY 2019) to -$70.37M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $67.90M | $1.67M | $163.80M | $1.24M | $153.19M | $65.97M |